Fund Holdings — TAKEDA PHARMACEUTICAL CO LTD

Total Portfolio Value:
$19.55M
Total Bought:
$0
Total Sold:
$79.0K
Net Transaction:
-$79.0K
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
HilleVax, Inc.6,724,0006,724,0000$9.75M$13.38M68.43%+$3.63M
Ovid Therapeutics Inc.(OVID)7,531,9967,531,9960$2.35M$2.49M12.71%+$135.6K
Xilio Therapeutics, Inc.(XLO)1,475,1211,475,1210$1.07M$1.00M5.13%-$65.1K
American Well Corporation(AMWL)77,73377,7330$612.5K$691.0K3.53%+$78.5K
Equillium, Inc.(EQ)1,824,9771,824,9770$711.7K$575.2K2.94%-$136.5K
Shattuck Labs, Inc.(STTK)515,619515,6190$489.8K$408.3K2.09%-$81.6K
Lyell Immunopharma, Inc.(LYEL)823,31741,165-782,152$442.9K$363.9K1.86%-$79.0K
Turnstone Biologics895,824895,8240$367.3K$321.6K1.64%-$45.7K
Third Harmonic Bio, Inc.36,83536,8350$127.8K$200.0K1.02%+$72.2K
Rani Therapeutics Holdings, Inc.(RANI)203,190203,1900$256.0K$104.4K0.53%-$151.6K
Standard BioTools Inc.(LAB)16,51516,5150$17.8K$19.8K0.10%+$2.0K
Page 1 of 1